News and Press - JDRF T1D Fund

SAB Biotherapeutics Appoints Katie Ellias to the Board of Directors

November 20, 2023 | SIOUX FALLS, S.D.

Timothy Clark Elected Chair of the JDRF T1D Fund

October 19, 2023 | Boston, MA

SAB Biotherapeutics Announces Private Placement of up to $130 Million to Advance Development of Lead Drug Candidate for Type 1 Diabetes

October 02, 2023

T1D Fund in the News

Sean Doherty has been honored as a PharmaVoice 100 winner.

September 25, 2023

Seraxis announces closing of second VC tranche and successful completion of preclinical studies of pancreatic organoids from Seraxis’ novel pancreas-derived stem cells

September 21, 2023